Formation of a Stable Six-Coordinate Species
A R T I C L E S
(CH2)n tether (n ) 0-8).9 Later, Momenteau and co-workers
were able to improve the solubility of imidazole-tethered
protohemes through the use of propionic acid side chains.6b,10
While a considerable amount of insight has been gained from
these ꢀ-pyrrole and propionic acid tethered model systems, they
have been shown to exhibit undesirable intermolecular binding
through the tethered donor ligands.10 As an alternative, the use
of tetraphenylporphyrin derivatives offers a convenient strategy
for attaching such tethers by substituting the ortho positions of
the meso-phenyl groups available in these systems. These
models offer the distinct benefit that, due to the perpendicular
orientation of the phenyl rings with respect to the porphyrin
plane, ortho-phenyl substituents are conveniently directed
toward the axial positions of the heme center and thus,
intermolecular interactions are avoided. Collman and co-workers
have shown the utility of such systems through their use of
multitethered “picket fence porphyrins” which employ either
ether or amide linkages.11-13 Walker and co-workers have also
utilized such porphyrin model systems to elucidate the properties
of cytochromes c, b, and a3 with respect to axial N-donor ligand
geometry.14,4a,15 Recently, model systems from the Collman,
Karlin, and Naruta groups have continued to exploit the
effectiveness of meso-phenyl tethered porphyrin systems in their
models for the active site of cytochrome c oxidase.16-19
Our particular interest is focused on bacterial nitric oxide
reductase (NorBC) which is an enzyme found in soil dwelling
bacteria that is responsible for the conversion of nitric oxide
(NO) to nitrous oxide (N2O) via a two-electron reduction:
seen in the heme active sites of Hb and Mb. The dimetallic
heme/nonheme motif is catalytically active in the diferrous
form.20 Detailed investigations into the properties and reactivity
of the heme component of the active site of NorBC could, in
principle, be based on the Mb and Hb model complexes
described above. However, in the case of NorBC, the interaction
of NO, rather than O2 or CO, with ferrous heme model
complexes needs to be studied to arrive at a detailed structural
and mechanistic understanding of this enzyme. This has
important consequences for the design of model systems as the
generation of six-coordinate (6C) ferrous heme nitrosyls con-
stitutes a significant challenge.
The question of axial ligand binding is of direct relevance
for the reactivity of ferrous heme nitrosyls. It has been shown
that the trans ligand modulates the amount of radical character
on the NO, and hence, the chemical behavior of these
complexes. This is evident from spectroscopic studies including
EPR, MCD, vibrational spectroscopy (coupled to normal
coordinate analysis), and DFT calculations on five- and six-
coordinate ferrous heme nitrosyl model systems.22 In five-
coordinate (5C) complexes a strong Fe-NO σ-bond is present
2
between the singly occupied π* orbital of NO and dz of
Fe(II).22a,b Additional backbonding is observed between the dxz
and dyz orbitals of iron and the remaining unoccupied π* orbital
of NO. The strong σ-bond and substantial sharing of the
2
unpaired electron via the dz orbital of iron gives rise to the
strong σ-trans interaction between NO and the proximal
N-donor ligand in the corresponding 6C complexes. This has
two consequences: (a) the binding of axial ligands trans to NO
is weak, and (b) upon coordination of an N-donor ligand trans
to NO, the Fe-NO bond is weakened and the unpaired electron
is pushed back from the iron(II) to the NO ligand resulting in
an electronic structure with Fe(II)-NO(radical) character in the
6C case.22a,b In this way, the N-donor ligand could help to
activate the bound NO for catalysis. This is particularly relevant
for the activation of NO in NorBC since ferrous heme nitrosyls
are intrinsically stable and unreactive.23
To investigate this point further, 6C ferrous heme nitrosyl
model complexes that are stable in solution at room temperature
are needed. This is challenging because the binding constants
of N-donor ligands trans to NO are generally very small (Keq
≈ 1 to 30 M-1) due to the σ-trans effect detailed above.22b,24
This is very different compared to CO and O2 complexes where
such a trans effect is lacking. Correspondingly, a recent report
on Fe(II)-NO complexes of protoheme with covalently linked
IM shows that these complexes are indeed only 5C in solution.25
In fact, only one model complex is known so far where the
covalently tethered N-donor ligand seems to remain bound to
iron(II) after coordination of NO without the formation of 5C
species in solution.26 Systematic investigations to optimize axial
ligand binding properties in tailed ferrous heme nitrosyl model
systems are completely lacking. It is apparent from the literature
2NO + 2e- + 2H+ f N2O + H2O
(1)
This enzyme fulfills a vital role in the process of denitrifi-
cation where nitrate is reduced in a stepwise fashion to
dinitrogen.20 The site of catalytic NO reduction within the
enzyme consists of a dinuclear iron center with both heme and
nonheme type coordination. The nonheme iron site has three
histidine ligands and has been proposed to also contain glutamate
ligation.21 Located 3.5 Å from the nonheme iron is a heme b
site with additional proximal histidine ligation similar to that
(9) Paine, J. B., III; Dolphin, D. Can. J. Chem. 1978, 56, 1710–1712.
(10) Momenteau, M.; Rougee, M.; Loock, B. Eur. J. Biochem. 1976, 71,
63–76.
(11) Collman, J. P.; Gagne, R. R.; Halbert, T. R.; Marchon, J. C.; Redd,
C. A. J. Am. Chem. Soc. 1973, 95, 7868–7870.
(12) Collman, J. P.; Gagne, R. R.; Reed, C. A. J. Am. Chem. Soc. 1974,
96, 2629–2631.
(13) Gerothanassis, I. P.; Momenteau, M.; Barrie, P. J.; Kalodimos, C. G.;
Hawkes, G. E. Inorg. Chem. 1996, 35, 2674–2679.
(14) Safo, M. K.; Gupta, G. P.; Walker, F. A.; Scheidt, W. R. J. Am. Chem.
Soc. 1991, 113, 5497.
(15) Walker, F. A.; Reis, D.; Balke, V. L. J. Am. Chem. Soc. 1984, 106,
6888–6898.
(16) Kopf, M. A.; Karlin, K. D. Inorg. Chem. 1999, 38, 4922–4923.
(17) Kim, E.; Shearer, J.; Lu, S.; Moënne-Loccoz, P.; Helton, M. E.;
Kaderli, S.; Zuberbhler, A. D.; Karlin, K. D. J. Am. Chem. Soc. 2004,
126, 12716–12717.
(22) (a) Praneeth, V. K. K.; Neese, F.; Lehnert, N. Inorg. Chem. 2005, 44,
2570. (b) Praneeth, V. K. K.; Na¨ther, C.; Peters, G.; Lehnert, N. Inorg.
Chem. 2006, 45, 2795. (c) Praneeth, V. K. K.; Haupt, E.; Lehnert, N.
J. Inorg. Biochem. 2005, 99, 940 Erratum: Praneeth, V. K. K.; Haupt,
E.; Lehnert, N. J. Inorg. Biochem. 2005, 99, 1744. (d) Lehnert, N.;
Praneeth, V. K. K.; Paulat, F. J. Comput. Chem. 2006, 27, 1338.
(23) Lim, M. D.; Lorkovic, I. M.; Ford, P. C. J. Inorg. Biochem. 2005, 99,
151.
(18) Liu, J.-G.; Naruta, Y.; Tani, F. Angew. Chem. 2005, 117, 1870–1874.
(19) (a) Collman, J. P.; Ghosh, S.; Dey, A.; Decreau, R. A.; Yang, Y. J. Am.
Chem. Soc. 2009, 131, 5034–5035. (b) Collman, J. P.; Fu, L.;
Herrmann, P. C.; Zhang, X. Science 1997, 275, 949–951. (c) Collman,
J. P.; Devaraj, N. K.; Decreau, R. A.; Yang, Y.; Yan, Y.-L.; Ebina,
W.; Eberspacher, T. A.; Chidsey, C. E. D. Science 2007, 315, 1565–
1568. (d) Collman, J. P.; Dey, A.; Decreau, R. A.; Yang, Y.; Hosseini,
A.; Solomon, E. I.; Eberspacher, T. A. Proc. Natl. Acad. Sci. U.S.A.
2008, 105, 9892–9896.
(24) (a) Bohle, D. S.; Hung, C.-H. J. Am. Chem. Soc. 1995, 117, 9584. (b)
Choi, I.-K.; Ryan, M. D. Inorg. Chim. Acta 1988, 153, 25. (c) Liu,
Y.; DeSilva, C.; Ryan, M. D. Inorg. Chim. Acta 1997, 258, 247.
(25) Cullotti, M.; Santagostini, L.; Monzani, E.; Casella, L. Inorg. Chem.
2007, 46, 8971.
(20) Zumft, W. G. J. Inorg. Biochem. 2005, 99, 194–215.
(21) Butland, G.; Spiro, S.; Watmough, N. J.; Richardson, D. J. J. Bacteriol.
2001, 183, 189–199.
9
J. AM. CHEM. SOC. VOL. 131, NO. 47, 2009 17117